-transparent.png){kind=logo}
BACKGROUND The use of intravenous bicarbonate in diabetic ketoacidosis (DKA) may be considered for patients with a pH less than 6.9 according to the American Diabetes Association. The impact of this therapy on resolution of acidosis in patients with DKA is unclear. OBJECTIVE To determine whether the use of intravenous bicarbonate therapy was associated with improved outcomes in patients with severe DKA who were seen in the emergency department. METHODS This review was conducted from 2007 to 2011 in the emergency department of a tertiary teaching hospital. Adults diagnosed with DKA with an initial pH less than 7.0 were included. Patients were stratified into 2 groups based on receipt of intravenous bicarbonate. The primary study outcome was time to resolution of acidosis, defined as return to pH greater than 7.2. Secondary outcomes included length of stay; continuous infusion insulin use; and intravenous fluid, po tas si um, and insulin requirements within the first 24 hours of hospital admission, beginning upon admittance to the emergency department. We also conducted a subgroup analysis of patients with an initial pH less than 6.9. RESULTS There was no significant difference in time to resolution of acidosis (8 hours vs 8 hours; p = 0.7) or time to hospital discharge (68 hours vs 61 hours; p = 0.3) between patients who received intravenous bicarbonate (n = 44) compared with those who did not (n = 42). The median dose of intravenous bicarbonate was 100 mEq (100-150) for patients who received intravenous bicarbonate. Insulin and fluid requirements in the first 24 hours were significantly higher in patients who received intravenous bicarbonate compared with those who did not (100 units vs 86 units; p = 0.04 and 7.6 L vs 7.2 L; p = 0.01, respectively). There was no significant difference in hours of continuous insulin infusion (27 hours vs 26 hours; p = 0.09) or potassium requirements in the first 24 hours of hospital stay (135 mEq vs 120 mEq; p = 0.84). CONCLUSIONS Intravenous bicarbonate therapy did not decrease time to resolution of acidosis or time to hospital discharge for patients with DKA with an initial pH less than 7.0.
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
June 2014,
The Annals of pharmacotherapy,
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
August 1983,
The American journal of medicine,
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
January 2013,
The journal of trauma and acute care surgery,
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
January 2008,
Bratislavske lekarske listy,
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
April 1987,
Annals of internal medicine,
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
December 1986,
Annals of internal medicine,
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
January 1996,
The Journal of clinical endocrinology and metabolism,
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
November 2002,
American journal of respiratory and critical care medicine,
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
February 2009,
Pediatrics,
Bryson Duhon, and
Rebecca L Attridge, and
A Crystal Franco-Martinez, and
Pamela R Maxwell, and
Darrel W Hughes
March 2009,
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
